By employing pharmacological (inflammasome inhibitors) and genetic approaches (NLRP3-/- mice and VSMC specific TXNIP deletion mice), we aimed to determine the effect and molecular mechanisms of inflammasome activation on atherosclerosis and atherosclerotic plaque stability. Here, NLRP3 is linked to atherosclerosis.